DAVY VIEW

Givaudan’s recent half-year investor conference added substance to its 2025 strategy. The conference centered on the CHF14bn addressable market for Nutrition and Functional Ingredients and Givaudan’s associated capability set (giving credence to the Naturex acquisition). Its go-to-market strategy remains anchored by high value-add ingredients that facilitate product differentiation for its broad customer set. Givaudan’s functional ingredient capabilities impressed, allied with a burgeoning ingredient solutions ethos and a continued cycle of food and beverage renovation provides confidence on growth sustainability over the long run.